Friedland D - Search Results

1

Phase I clinical/pharmacokinetic and pharmacodynamic trial of the c-raf-1 antisense oligonucleotide ISIS 5132 (CGP 69846A).

Stevenson JP, Yao KS, Gallagher M, Friedland D, Mitchell EP, Cassella A, Monia B, Kwoh TJ, Yu R, Holmlund J, Dorr FA, O'Dwyer PJ. Stevenson JP, et al. Among authors: friedland d. J Clin Oncol. 1999 Jul;17(7):2227-36. doi: 10.1200/JCO.1999.17.7.2227. J Clin Oncol. 1999. PMID: 10561280 Clinical Trial.

2

Phase I and pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with refractory advanced cancers.

Ramanathan RK, Egorin MJ, Eiseman JL, Ramalingam S, Friedland D, Agarwala SS, Ivy SP, Potter DM, Chatta G, Zuhowski EG, Stoller RG, Naret C, Guo J, Belani CP. Ramanathan RK, et al. Among authors: friedland d. Clin Cancer Res. 2007 Mar 15;13(6):1769-74. doi: 10.1158/1078-0432.CCR-06-2233. Clin Cancer Res. 2007. PMID: 17363531 Clinical Trial.

3

A phase II trial of docetaxel (Taxotere) in hormone-refractory prostate cancer: correlation of antitumor effect to phosphorylation of Bcl-2.

Friedland D, Cohen J, Miller R Jr, Voloshin M, Gluckman R, Lembersky B, Zidar B, Keating M, Reilly N, Dimitt B. Friedland D, et al. Semin Oncol. 1999 Oct;26(5 Suppl 17):19-23. Semin Oncol. 1999. PMID: 10604264 Clinical Trial.

4

Phase I and pharmacokinetic study of pegylated liposomal CKD-602 in patients with advanced malignancies.

Zamboni WC, Ramalingam S, Friedland DM, Edwards RP, Stoller RG, Strychor S, Maruca L, Zamboni BA, Belani CP, Ramanathan RK. Zamboni WC, et al. Clin Cancer Res. 2009 Feb 15;15(4):1466-72. doi: 10.1158/1078-0432.CCR-08-1405. Epub 2009 Feb 3. Clin Cancer Res. 2009. PMID: 19190127 Free PMC article. Clinical Trial.

5

A Phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors.

Ramanathan RK, Kirkpatrick DL, Belani CP, Friedland D, Green SB, Chow HH, Cordova CA, Stratton SP, Sharlow ER, Baker A, Dragovich T. Ramanathan RK, et al. Among authors: friedland d. Clin Cancer Res. 2007 Apr 1;13(7):2109-14. doi: 10.1158/1078-0432.CCR-06-2250. Clin Cancer Res. 2007. PMID: 17404093 Clinical Trial.

6

Phase I and pharmacologic study of intermittently administered 9-nitrocamptothecin in patients with advanced solid tumors.

Zamboni WC, Jung LL, Egorin MJ, Potter DM, Friedland DM, Belani CP, Agarwala SS, Wong MM, Fakih M, Trump DL, Jin R, Strychor S, Vozniak M, Troetschel M, Ramanathan RK. Zamboni WC, et al. Clin Cancer Res. 2004 Aug 1;10(15):5058-64. doi: 10.1158/1078-0432.CCR-03-0288. Clin Cancer Res. 2004. PMID: 15297407 Clinical Trial.

7

Phase II study of everolimus (RAD001) in previously treated small cell lung cancer.

Tarhini A, Kotsakis A, Gooding W, Shuai Y, Petro D, Friedland D, Belani CP, Dacic S, Argiris A. Tarhini A, et al. Among authors: friedland d. Clin Cancer Res. 2010 Dec 1;16(23):5900-7. doi: 10.1158/1078-0432.CCR-10-0802. Epub 2010 Nov 2. Clin Cancer Res. 2010. PMID: 21045083 Clinical Trial.

8

Phase II trial of all-trans retinoic acid in metastatic non-small cell lung cancer.

Treat J, Friedland D, Luginbuhl W, Meehan L, Gorman G, Miller W Jr, Bavaria J, Kaiser L. Treat J, et al. Among authors: friedland d. Cancer Invest. 1996;14(5):415-20. doi: 10.3109/07357909609018898. Cancer Invest. 1996. PMID: 8816856 Clinical Trial.

9

A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies.

Ramalingam SS, Egorin MJ, Ramanathan RK, Remick SC, Sikorski RP, Lagattuta TF, Chatta GS, Friedland DM, Stoller RG, Potter DM, Ivy SP, Belani CP. Ramalingam SS, et al. Clin Cancer Res. 2008 Jun 1;14(11):3456-61. doi: 10.1158/1078-0432.CCR-07-5088. Clin Cancer Res. 2008. PMID: 18519777 Clinical Trial.

10

A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancer.

Matin K, Jacobs SA, Richards T, Wong MK, Earle M, Evans T, Troetschel M, Ferri W, Friedland D, Pinkerton R, Volkin R, Wieand S, Ramanathan RK. Matin K, et al. Among authors: friedland d. Am J Clin Oncol. 2005 Oct;28(5):439-44. doi: 10.1097/01.coc.0000170797.36351.3a. Am J Clin Oncol. 2005. PMID: 16199980 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters